Patents
Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
08/2007
08/15/2007EP1817038A2 Combination comprising zd6474 and an antiandrogen
08/15/2007EP1435947B1 2-phenyl benzimidazoles and imidazo-¬4,5|-pyridines as cds1/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
08/15/2007EP1100576B1 Synergism of photodynamic and electropermeation effects on cell vitality as a novel cytotoxic agent
08/14/2007US7256026 Activated yeast cell culture for improving immune functions of animals; health foods, drinks and supplement; immunosuppression; immunotherapy
08/09/2007US20070185124 Cancer treatment with topoisomerase-ii inhibitor, a bis-dioxypiperazine and radiation
08/08/2007EP1349962A4 Methods and compositions for detecting polynucleotide duplex damage
08/08/2007CN101014713A Method for introducing a pna molecule conjugated to a positively charged peptide into the cytosol and/or the nucleus by photochemical internalisation (PCI)
08/07/2007US7252815 using carbocyanine dye; photodynamic therapy; supplying to tumor
08/07/2007CA2289088C Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream
08/01/2007EP1812020A1 Presbyopia treatment by lens alteration
08/01/2007EP1811994A1 Novel derivatives of porphyrin, particularly chlorins and/or bacteriochlorins, and uses thereof in photodynamic therapy
07/2007
07/26/2007WO2007084670A2 Specific therapy using integrin ligands for treating cancer
07/26/2007US20070173913 Methods and devices for epithelial protection during photodynamic therapy
07/26/2007US20070172849 Detection of markers in nascent proteins
07/26/2007CA2637387A1 Specific therapy using integrin ligands for treating cancer
07/25/2007EP1810688A1 Pharmaceutical preparation containing coated magnetic particles and method for production thereof, and diagnosis therapy system
07/25/2007EP1534346A4 Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues
07/25/2007EP1444236B1 Separation of regioisomers of metal phthalocyanines
07/25/2007EP1073475B1 Improvements in or relating to diagnostic/therapeutic agents
07/25/2007EP0840624B1 Apparatus for inactivating viral contaminants in blood products
07/24/2007US7247655 Such as methyl-5-aminolevulinate hydrochloride; porphyrins; antitumor agents; anticancer agents
07/24/2007US7247444 Use of interleukin-19 to treat cervical cancer
07/24/2007CA2110491C Gas filled liposomes and their use as ultrasonic contrast agents
07/19/2007US20070167644 Bifunctional energy-reversible acyl-compositions
07/18/2007EP1808158A2 Presbyopia treatment by lens alteration
07/18/2007EP1807115A1 Nanoparticles comprising an intracellular targeting element and preparation and use thereof
07/12/2007WO2007077566A1 Amphiphilic squaraine dyes, process for preparation thereof and use thereof
07/12/2007WO2007076832A1 Method for the inactivation of pathogens in donor blood, blood plasma or erythrocyte concentrations in flexible containers using agitation
07/12/2007WO2007042833A3 Arnphiphilic nanotubes and micelles comprising same for use in the delivery of biologically active agents
07/12/2007WO2006111971A3 Photodynamic therapy using chemiluminescence and a ligand-photosensitiser conjugate
07/12/2007WO2006107598A3 Conjugates of photoactive compound and a bulking group for enhancing photodynamic therapy
07/12/2007WO2003077723A3 Methods and devices for detection and therapy of atheromatous plaque
07/12/2007US20070158273 Has ultrasound emitter located relative to compartment of container holding liquid medium and microbubble emitter relative to compartment; produces water supersaturated with salts to induce biotoxic effects on microorganisms
07/12/2007CA2632558A1 Method for the inactivation of pathogens in donor blood, blood plasma or erythrocyte concentrations in flexible containers using agitation
07/11/2007EP1804802A2 Combination comprising zd6474 and an imatinib
07/10/2007CA2098849C Control of gene expression by ionizing radiation
07/05/2007WO2006131840A3 Method and apparatus for ultrasound drug delivery and thermal therapy with phase-convertible fluids
07/05/2007US20070151631 Magnetic nanoparticles of noble metals
07/04/2007EP1803467A1 Composite fine particles and process for producing the same
07/04/2007EP1124982B1 THE HEMATOPOIETIC, MYELOPROTECTING, ANTITUMOR IMMUNE CELLS GENERATING AND RADIOSENSITIZING POLYSACCHARIDE ISOLATED FROM i PANAX GINSENG /i
06/2007
06/28/2007US20070149917 Ultrasound catheter
06/28/2007US20070149553 2,3-Diphenylquinazolin-4(3H)-one compounds; anticarcinogenic agents can be synergistically combined with one or more active ingredients; side effect reduction
06/28/2007US20070149498 Cancer therapy
06/28/2007US20070149496 Water-soluble compound
06/28/2007US20070148680 Detection of disease related genes
06/28/2007US20070148630 Removal of Adenine During a Pathogen Reduction Process in Whole Blood or Red Blood Cells by Dilution
06/28/2007US20070148437 Thermosensitive, biocompatible polymer carriers with changeable physical structure for therapy, diagnostics and analytics
06/27/2007EP1799748A1 Biodegradable cationic polymers
06/27/2007EP1799720A1 Assay methods, materials and preparations
06/27/2007EP0863903B1 Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof
06/27/2007CN1988848A Carboranylporphyrins and uses thereof
06/26/2007US7235685 Of tumors and other lesions; phototherapeutic effect is caused by direct interaction of free radicals, the reactive intermediate produced upon photofragmentation of the sulfenate moiety, with the tissue of interest
06/26/2007US7235392 Transforming B lymphocytes with Epstein-Barr virus, incubating transformed B lymphocytes with flavin N-oxide photosensitizer, adding non-toxic antioxidant, and exposing lymphocytes to activator such as photoradiation to activate photosensitizer
06/21/2007US20070142466 Photoreactive compounds and compositions
06/21/2007US20070141169 Homeopathic drug composition and methods of use thereof
06/20/2007EP1797890A1 A method for obtaining a biologically active fraction of blood serum treated with gamma irradiation and the use thereof
06/19/2007CA2482021C Removal of adenine during a process of pathogen reducing blood and blood components
06/14/2007WO2007065714A1 A method for obtaining a biologically active fraction of blood serum treated with gamma irradiation and the use thereof
06/14/2007WO2007019845B1 Method for encapsulating therapeutic substances in cells
06/14/2007US20070134758 Methods of inhibiting hiv-1 vpr activity and hiv-1 infectivity using atr or rad17 inhibitors
06/14/2007DE19936997B4 Verfahren zur Applikation von Photosensibilisatoren (PS) mittels Multiplikatoren in der photodymamischen Therapie A process for the application of photosensitizers (PS) by means of multipliers in the therapy photodymamischen
06/13/2007EP1357944B1 Perylenequinones for use with immunotherapy agents
06/13/2007EP1320383B1 Photosensitisers
06/13/2007EP0988060B1 Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy
06/13/2007CN1980661A Cationic bacteriochlorophyll derivatives and uses thereof
06/13/2007CN1980651A Treatment of myopia
06/12/2007US7230088 Compounds for dual photodiagnosis and therapy
06/12/2007US7229621 Method to enhance the immunogenicity of an antigen
06/12/2007US7229447 Photodynamic therapy utilizing a solution of photosensitizing compound and surfactant
06/07/2007WO2005020918A3 Ultrasonic concentration of drug delivery capsules
06/07/2007US20070129411 Treatment of proliferative diseases with epothilone derivatives and radiation
06/07/2007US20070128115 Pathological tissue detection and treatment employing targeted benzoindole optical agents
06/06/2007EP1476548B1 Process of cell electrofusion
06/06/2007EP1289556B1 Isoflavones against radiation-induced mortality
06/05/2007US7226600 Comprising live yeast cells produced by culturing yeast cells in the presence of a series of electromagnetic fields such that the yeast cells become metabolically active
05/2007
05/31/2007WO2007011680A3 Ligands to radiation-induced molecules
05/31/2007WO2007004045A9 Use of a photosensitizing agent in the treatment or prevention of an inflammation-associated disorder in the gastrointestinal tract of a mammal
05/30/2007EP1790642A1 Biologically active methylene blue derivatives
05/30/2007EP1789361A1 Water-soluble nanoparticles stabilized with multi-functional group ligands and method of preapation thereof
05/30/2007EP1496925A4 Use of interleukin-24 to treat ovarian cancer
05/30/2007EP1492560A4 Use of interleukin-19 to treat cervical cancer
05/30/2007EP1091742A4 Indium photosensitizers for pdt
05/30/2007CN1318388C Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
05/29/2007US7223600 cell is contacted with a photosentistising agent, cell is irradiated with light to activate photosentisitising agent, the cell is contacted with the molecule to be introduced, particularly for use in cancer treatment, gene therapy and vaccination
05/29/2007US7223405 Comprising live yeast cells produced by culturing yeast cells in the presence of a series of electromagnetic fields such that the yeast cells become metabolically active
05/29/2007US7223404 Comprising live yeast cells produced by culturing yeast cells in the presence of a series of electromagnetic fields such that the yeast cells become metabolically active
05/29/2007US7223403 Method to prepare compositions comprising yeast treated with electromagnetic energy
05/29/2007US7223402 Comprising live yeast cells produced by culturing yeast cells in the presence of a series of electromagnetic fields such that the yeast cells become metabolically active
05/29/2007US7223401 Method to prepare compositions comprising yeast treated with electromagnetic energy
05/29/2007US7223400 Method to prepare compositions comprising yeast treated with electromagnetic energy
05/29/2007US7223391 Administering subject's modified blood on consecutive days; blood is modified extracorporeally by exposure from 2 to 5 minutes to a combination of stressors; treating ischemic stress, atherosclerosis and rheumatoid arthritis
05/23/2007EP1786431A2 Improved photosensitizer formulations and their use
05/23/2007CN1968705A Carboranylporphyrins and uses thereof
05/22/2007US7220778 Methods and devices for epithelial protection during photodynamic therapy
05/22/2007US7220747 Selected from the group consisting of alloxazines and photosensitizers
05/22/2007US7220416 Method to prepare compositions comprising yeast treated with electromagnetic energy
05/18/2007WO2007019865A3 Therapy with cd4 binding peptides and radiation
05/17/2007US20070112042 Topical agent for application to the skin prior to luminous treatment
05/17/2007US20070110667 Radionuclide labeling of vitamin B12 and coenzymes thereof
05/16/2007EP1784494A1 Method for introducing a pna molecule conjugated to a positively charged peptide into the cytosol and/or the nucleus by photochemical internalisation (pci)
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 95